News

The George Washington University (GW) works with many researchers with current projects either in development, or that have commercial potential. One of the goals of the GW Technology Commercialization Office is to highlight GW's research news so the outside community can learn a little about the tireless work from our GW researchers as well as the robustness of the technology that we have available.

 



TCO and SMHS Team Working Together to Make GW a Preeminent Research University

August 16, 2019

GW Today (Aug 16, 2019) - Engagement between TCO and faculty has increased in th

WBJ - GW developed life-saving drug. Sold some royalty rights in 8-figure deal

August 16, 2019

Washington Business Journal (Aug 16, 2019) - 

GW TCO Hosts 2019 Innovation Competition

April 22, 2019

Twelve groups of GW researchers vied for $30,000 in prizes at the 2019 TCO Innovation Competition.

GW TCO Senior Licensing Associate, Dr. Brian Coblitz, Contributes to Bloomberg Law Article titled "The Effect of Intellectual Property Ownership on Biotechnology Development Strategies"

April 05, 2019

GW TCO Senior Licensing Associate, Dr. Brian Coblitz, contributes to Bloomberg Law article titled "The Effect of Intellectual Property Ownership on Biotechnology Development Strategies".

Biomedical Engineering Chair to Be Inducted in National Academy of Inventors

December 11, 2018

Igor Efimov, a SEAS professor who specializes in developing novel therapies for heart diseases, was nominated for his contributions to innovation and is set to be inducted into the National Academy

GW Licensee, Vector, Secures $70 Million Series B Round to Move into Full Operations

October 19, 2018

 GW licensee, Vector, secures $70 Million Series B round to mve into full operations.

Welltok Acquires GW Licensee to Expand Medicaid and Government Business

September 12, 2018

Welltok acquires GW licensee to expand medicaid and government business.

GW Licensee, La Jolla Pharmaceuticals, Receives Additional Medicare Coverage for GIAPREZA™

August 03, 2018

GW licensee, La Jolla Pharmaceuticals, receives additional medicare coverage for GIAPREZA™.

Charles Andres, of WSGR, presents on Venture Market and Investment Strategies at GW TCO's Inaugural Startup Showcase

April 20, 2018

Charles Andres, of the Wilson Sonsini Goodrich & Rosait law firm, presents on venture market and investment strategies at GW TCO's Inaugural Startup Showcase.

GW Researcher Advances to the Final Round of NRG COSIA Carbon XPRIZE

April 09, 2018

A team of George Washington University researchers have been named as finalists in the $20 million

GW TCO's Commercialization Efforts Bring Research with ‘Broad Benefits’ to Market

March 07, 2018

GW TCO has successfully licensed GiaprezaTM (Angiotensin II) to La Joll